Armstrong Advisory Group’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29K Hold
63
﹤0.01% 933
2026
Q1
$1.39K Hold
63
﹤0.01% 902
2025
Q4
$743 Hold
63
﹤0.01% 925
2025
Q3
$998 Hold
63
﹤0.01% 901
2025
Q2
$722 Hold
63
﹤0.01% 889
2025
Q1
$1.06K Hold
63
﹤0.01% 807
2024
Q4
$1.06K Hold
63
﹤0.01% 807
2024
Q3
$1.28K Hold
63
﹤0.01% 747
2024
Q2
$1.42K Hold
63
﹤0.01% 748
2024
Q1
$1.99K Hold
63
﹤0.01% 718
2023
Q4
$1.99K Hold
63
﹤0.01% 718
2023
Q3
$1.77K Hold
63
﹤0.01% 787
2023
Q2
$2.33K Hold
63
﹤0.01% 731
2023
Q1
$1.89K Hold
63
﹤0.01% 717
2022
Q4
$1.93K Buy
+63
New +$1.89K ﹤0.01% 744

Other funds holding CC

Armstrong Advisory Group's CC Position: Q2 2026 in Review

Armstrong Advisory Group held its Chemours (CC) position steady in Q2 2026 at 63 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Armstrong Advisory Group first reported a position in CC in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.33K in Q2 2023. 59 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Armstrong Advisory Group held 63 shares of Chemours worth $1.29K as of Q2 2026.
  • Armstrong Advisory Group left its Chemours share count unchanged in Q2 2026.
  • Chemours made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #933 holding.
  • Armstrong Advisory Group first reported a position in Chemours in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Chemours position peaked at $2.33K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.